Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Ophthalmologe ; 110(8): 728-32, 2013 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-23873397

RESUMO

Epibulbar glaucoma drainage devices have been only slightly modified since their introduction more than 40 years ago. Having been used primarily in only difficult cases with a poor prognosis (and therefore with poor clinical results) the recently published trabeculectomy versus tube study (TVT) led to a change in our understanding of these devices. In this study epibulbar glaucoma drainage devices (here the Baerveldt device) were employed for early implantation (in some cases as primary glaucoma surgery intervention). Being sceptically monitored the results over the first 5 year clearly showed an almost equal or even better outcome in comparison to trabeculectomy. Despite these good results a critical evaluation seems mandatory mainly because of the unsolved problems concerning late complications. Late tube erosion with subsequent blebitis and enophthalmitis as well as late base plate encapsulation need to be mentioned here. The latter leads to thick fibrous tissue around the base plate resulting in an increase of intraocular pressure (IOP). Late corneal decompensation is also a late complication the pathomechanism of which is only poorly understood. Solving and treating such late complications are often troublesome and time consuming. Future experiments should lead to development of new drainage implant designs and the bulk material should be enhanced and optimized to increase clinical surgical results.


Assuntos
Implantes para Drenagem de Glaucoma , Glaucoma/etiologia , Glaucoma/terapia , Hipertensão Ocular/complicações , Hipertensão Ocular/terapia , Trabeculectomia/instrumentação , Trabeculectomia/métodos , Análise de Falha de Equipamento , Medicina Baseada em Evidências , Humanos , Desenho de Prótese , Resultado do Tratamento
3.
Ophthalmic Res ; 48(4): 171-6, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22710976

RESUMO

PURPOSE: To report a series of 3 patients with soft contact lens-related Fusarium keratitis. Two of them were treated with the antiamoebic polyhexamethylene biguanide 0.02% (PHMB) in combination with antifungal drugs, and 1 patient was treated with PHMB as sole antifungal regimen. METHODS: Chart review of 3 patients treated with PHMB in Fusarium keratitis. Two of them were refractory to the commonly used therapy. The antifungal power of PHMB and propamidine isethionate was tested against the patients' isolates as well as against the clinical isolates from another 9 patients with ocular mould infections. RESULTS: An excellent outcome could be achieved in 2 patients with Fusarium solani keratitis refractory to common antifungal treatment by the additional use of PHMB 0.02%. In another patient PHMB alone was sufficient to resolve Fusarium proliferatum infection. The drug was well tolerated. In all patients repeated abrasion was done for better penetration of the drugs. PHMB revealed a marked in vitro antifungal activity for the three Fusarium isolates as well as for another 9 isolates of ocular infections from other patients including also the genera Scedosporium, Aspergillus and Rhizopus giving minimal inhibitory concentrations ranging from 1.56 to 3.12 µg/ml. CONCLUSIONS: Fusarium keratitis is a severe ocular infection. We report on the use of PHMB in 3 patients given additionally or as sole antifungal drug. We emphasize the benefit of PHMB 0.02% in Fusarium keratitis which might be considered as a therapeutic option especially in cases refractory to common antifungal therapy and possibly in keratitis due to other fungi.


Assuntos
Antifúngicos/uso terapêutico , Biguanidas/uso terapêutico , Úlcera da Córnea/tratamento farmacológico , Desinfetantes/uso terapêutico , Infecções Oculares Fúngicas/tratamento farmacológico , Fusariose/tratamento farmacológico , Fusarium/isolamento & purificação , Adulto , Antifúngicos/farmacologia , Benzamidinas/farmacologia , Benzamidinas/uso terapêutico , Biguanidas/farmacologia , Lentes de Contato Hidrofílicas/microbiologia , Úlcera da Córnea/microbiologia , Desinfetantes/farmacologia , Quimioterapia Combinada , Infecções Oculares Fúngicas/microbiologia , Feminino , Fungos/efeitos dos fármacos , Fusariose/microbiologia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Natamicina/farmacologia , Natamicina/uso terapêutico , Pirimidinas/farmacologia , Pirimidinas/uso terapêutico , Triazóis/farmacologia , Triazóis/uso terapêutico , Voriconazol
4.
Klin Monbl Augenheilkd ; 229(3): 246-54, 2012 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-21604236

RESUMO

Giant cell arteritis can cause diagnostic difficulties due to its heterogeneous symptomatology. Characteristic ophthalmic and systemic symptoms of Horton's disease are discussed. The clinical course is described on the basis of typical patients, which shows that generic symptoms do not have to coexist. The Horton's arteritis potentially represents a systemic vasculitis that requires early diagnosis and treatment in order to avoid dramatic ophthalmic consequences, in worst cases blindness. The erythrocyte sedimentation rate (ESR) represents the most important laboratory parameter. Although temporal artery biopsy remains the only confirmatory procedure for a definite diagnosis, imaging procedures such as sonography, magnetic resonance imaging, ultrasound biomicroscopy are useful in supporting the clinical diagnosis. Highly dosed corticosteroid therapy should always be indicated when suspicious clinical symptoms are present, even without any dramatic laboratory parameter changes. Initial high dosages are indicated up to 1 gram daily depending on the severity of the disease. Subsequently a slow ESR titrated reduction of the dose is necessary under control of inflammation values, symptomatology and side effects. Occasionally a lifelong immunsuppressive therapy is indispensable. The long-term treatment should take place in close cooperation with the general practitioner, rheumatologist, neurologist and if necessary further specialists.


Assuntos
Oftalmopatias/diagnóstico , Oftalmopatias/tratamento farmacológico , Arterite de Células Gigantes/diagnóstico , Arterite de Células Gigantes/tratamento farmacológico , Fatores Imunológicos/uso terapêutico , Imunossupressores/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Oftalmopatias/etiologia , Feminino , Arterite de Células Gigantes/complicações , Humanos , Masculino
5.
Ophthalmologe ; 106(5): 435-42, 2009 May.
Artigo em Alemão | MEDLINE | ID: mdl-18604542

RESUMO

Intravitreal anti-VEGF injections are currently the most effective treatment option for neovascular age-related macular degeneration. The anti-VEGF treatment of other, more common ocular diseases, such as diabetic retinopathy and vascular occlusions with neovascularization and retinal edema, is currently described in numerous studies and cases. Rare neovascular ocular diseases, such as Eales disease, presumed ocular histoplasmosis syndrome (POHS), retinopathy of prematurity, and idiopathic telangiectasia, may be future areas for anti-VEGF therapy. In our case report we describe intravitreal bevacizumab (Avastin) therapy for central serous chorioretinopathy and for pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization. In both cases the intravitreal injection resulted in morphological and functional rehabilitation.


Assuntos
Inibidores da Angiogênese/administração & dosagem , Anticorpos Monoclonais/administração & dosagem , Pseudoxantoma Elástico/tratamento farmacológico , Degeneração Retiniana/tratamento farmacológico , Anticorpos Monoclonais Humanizados , Bevacizumab , Feminino , Humanos , Injeções , Pessoa de Meia-Idade , Pseudoxantoma Elástico/diagnóstico , Doenças Raras/diagnóstico , Doenças Raras/tratamento farmacológico , Degeneração Retiniana/diagnóstico , Resultado do Tratamento
6.
Ophthalmologe ; 101(3): 278-84, 2004 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-15004715

RESUMO

BACKGROUND: Screening tests of visual functions using the Internet are theoretically possible. To use these tests as a screening test, they must deliver comparable results with conventional test procedures. A web-based color vision test was developed based on pseudoisochromatic color plates. METHOD: The web-based color vision test was developed according to the pseudoisochromatic color plates by Velhagen and Broschmann using the programming-languages HTML, Java, and Perl. Sixty-five voluntary subjects, including nine color-deficient subjects, were examined by luminescence color plates (via web-based color vision test) and pigment color plates (via book). The statistical analysis was performed by determining the correspondence and the 95%-confidence interval. RESULTS: The correspondence of the test results for all subjects was 0.98 and the 95%-confidence interval was within 0.91 and 0.99. The correspondence of the test results in the group of color-deficient subjects was 1.0 and because of the limited number the 95%-confidence interval was within 0.71 and 1.0. CONCLUSIONS: The web-based color vision test with luminescence color plates for color-efficient and color-deficient subjects delivers test results comparable to pigment color plates under standardized examination conditions. Further studies are needed to examine if the web-based color vision test can also be used as an Internet screening test.


Assuntos
Testes de Percepção de Cores/métodos , Percepção de Cores , Defeitos da Visão Cromática/diagnóstico , Internet , Adulto , Testes de Percepção de Cores/instrumentação , Intervalos de Confiança , Humanos , Medições Luminescentes
7.
Ophthalmologe ; 99(10): 768-73, 2002 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-12376852

RESUMO

BACKGROUND AND PURPOSE: Optic nerve head drusen (ONHD) are one of the most frequent causes for congenital swelling of the optic nerve head. Visual field and retinal nerve fiber layer defects are reported in cases of ONHD. The Heidelberg Retina Tomograph (HRT) allows a 3-dimensional topometric analysis of the optic nerve disc and measurement of the peripapillary mean retinal nerve fiber layer. PATIENTS AND METHODS: A total of 18 eyes from 9 patients with sonographically confirmed drusen were analyzed with the HRT. Data were compared to a control group of 18 eyes from 9 matched healthy individuals. Statistical analyses were performed by using ANOVA (univariate). All patients with ONHD underwent a computerised visual field test (30 degrees, Octopus 101). Due to a bad reliability factor of over 10 in the visual fields by 4 out of 18 eyes, only measurements from 14 eyes were included in the study. We correlated visual field and HRT parameters and calculated the Pearson's correlation coefficient (r). RESULTS: We found a significant difference in the measured parameter mean retinal nerve fiber layer (RNFL) thickness ( p<0.05) between the two groups. In the ONHD group a negative correlation coefficient was found between the peripapillary mean RNFL thickness and the loss variance (r=-0.50, p=0.03) as well as between the peripapillary RNFL cross-sectional area and the loss variance (r=-0.47, p=0.04). CONCLUSIONS: The HRT is able to detect a peripapillary RNFL thinning in cases with ONHD. The mean RNFL thickness correlated with the loss variance. The HRT should be used to perform a quantitative and objective topometric analysis in cases with ONHD.


Assuntos
Processamento de Imagem Assistida por Computador , Microscopia Confocal , Oftalmoscopia , Drusas do Disco Óptico/diagnóstico , Disco Óptico/patologia , Tomografia , Adulto , Idoso , Feminino , Angiofluoresceinografia , Humanos , Imageamento Tridimensional , Masculino , Pessoa de Meia-Idade , Fibras Nervosas/patologia , Retina/patologia , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA